Hutch News

Hutch News

Stories tagged 'Cancers'

Standard myeloma treatment reveals itself as an immunotherapy

Mouse study shows how transplanting patients’ own healthy blood stem cells can curb cancer, opening door to better treatments

Oct. 9, 2018 | By Susan Keown / Fred Hutch News Service

Despite conventional wisdom, a standard treatment for myeloma — autologous transplant — may be a type of immunotherapy, new research shows.

View story >


Hyundai Hope on Wheels presents Fred Hutch scientist with grant for childhood leukemia research

$300K Scholar Hope Grant will support Dr. Roland Walter’s research on acute myeloid leukemia

Sept. 27, 2018 | By Jill Christensen / Fred Hutch News Service

Hyundai Hope on Wheels Foundation has awarded Dr. Roland Walter, a clinical researcher at Fred Hutchinson Cancer Research Center, with a grant to support his pediatric leukemia research.

View story >


Fred Hutch metastatic breast cancer researcher gets 3-year Komen grant

Dr. Kevin Cheung’s work focuses on shutting down tumor cell clusters which seed new metastases

Sept. 26, 2018 | by Diane Mapes / Fred Hutch News Service

With the award, Cheung will conduct a preclinical study designed to prevent metastasis by eradicating tumor cell clusters.

View story >


Squelching ovarian cancer: the not-so-silent killer

The search continues for new biomarkers, better outcomes and, yes, cures for this deadly disease

Sept. 17, 2018 | By Diane Mapes / Fred Hutch News Service

September is Ovarian Cancer Awareness Month, but Fred Hutch researchers are working year-round to find ways to detect the disease early and shut it down for good. Read on for a handful of ovarian cancer research highlights.

View story >


Parsing the deadliness of prostate cancer

Fred Hutch researcher zeroes in on biomarkers to better predict aggressive form of the disease

Sept. 4, 2018 | By Diane Mapes / Fred Hutch News Service

Prostate cancers are not all the same. Some are extremely aggressive: They can and do kill. Others are slow-growing and don’t kill: Men die with them, not of them. How can doctors and patients discern which one is which? Fred Hutch's Dr. Janet Stanford believes she may have found a way.

View story >


Path to a targeted treatment for small-cell lung cancer?

Researchers show how common mutation in SCLC makes mouse tumors more vulnerable to certain cancer drugs

Sept. 4, 2018 | By Sabrina Richards / Fred Hutch News Service

Work by Dr. David MacPherson could point the way toward a targeted treatment for a subset of small-cell lung cancers. He showed that SCLC tumors with a specific DNA mutation are more vulnerable to certain drugs.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.